Gregg H. Alton

Companies

• NovavaxBoard member Nov 3, 2020 to now¹
• Corcept TherapeuticsBoard member Mar 13, 2020 to now²
• Lunai Bioworks Inc.Board member Jan 10, 2020 to Jun 27, 2024³
• Gilead SciencesSVP and Secretary Jul 6, 2009 to Mar 5, 2019⁴
• Eiger BioPharmaceuticals, Inc.Board member Jan 30, 2014 to Jun 5, 2015⁵
• Sonoma Pharmaceuticals, Inc.Board member Jan 28, 2008 to Oct 2, 2012⁶
• Gilead SciencesGeneral counsel Jan 27, 2006 to Jun 5, 2009⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Novavax NVAX47,685 shares⁸$516.0K at $10.82Jun 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 20, 2026Exercised options 18,880 shares of Novavax⁸
• Jun 12, 2025Exercised options 10,420 shares of Novavax⁹
• Dec 31, 2024Granted 1,982 shares at $8.61 of Novavax¹⁰
• Sep 30, 2024Granted 1,311 shares at $12.77 of Novavax¹⁰
• Jun 30, 2024Granted 1,202 shares at $13.93 of Novavax¹⁰
• Jun 12, 2024Exercised options 6,670 shares of Novavax¹¹
• Mar 31, 2024Granted 3,420 shares at $4.90 of Novavax¹⁰
• Jun 10, 2023Exercised options 3,100 shares of Novavax¹²
• Jun 17, 2022Exercised options 700 shares of Novavax¹³